Allergan botox growth strong, says Bernstein After surveying aesthetic doctors, Bernstein expects botox sales to rise 12% in 2014. The firm adds that fillers are growing at a 14% CAGR, with Allergan's share of that category holding at just under 50%. The firm keeps a $125 price target and Outperform rating on Allergan.
News For AGN From The Last 14 Days
Check below for free stories on AGN the last two weeks.